DLL3 and small cell lung carcinoma: Nie et al. demonstrated the potential therapeutic applications of TREM1 by developing a multichain DAP12/TREM1 CAR (DT CAR) targeting DLL3, which showed considerable antitumor effects in SCLC cells [90].